AIDS and Behavior

, Volume 23, Issue 1, pp 105–115 | Cite as

A Randomized Controlled Pilot Study of a Culturally-Tailored Counseling Intervention to Increase Uptake of HIV Pre-exposure Prophylaxis Among Young Black Men Who Have Sex with Men in Washington, DC

  • Aimee Desrosiers
  • Matthew Levy
  • Aurnell Dright
  • Maria Zumer
  • Nikardi Jallah
  • Irene Kuo
  • Manya Magnus
  • Marc SiegelEmail author
Original Paper


Daily emtricitabine/tenofovor is effective at preventing HIV acquisition and is approved for HIV pre-exposure prophylaxis (PrEP). Blacks in the United States have a disproportionately high rate of HIV, and uptake of PrEP has been very low in this population. We conducted a pilot study in a high-prevalence city to test whether a culturally-tailored counseling center for young Black men who have sex with men (BMSM) positively impacted their access and uptake of PrEP. 50 young BMSM were randomized to either a PrEP counseling center group or a control group, and were then encouraged to obtain PrEP from a PrEP provider. At the end of 3 month study, six participants in the intervention group compared with none in the control group had initiated PrEP (p = 0.02). This pilot study demonstrates that a culturally-tailored counseling center might be an effective at increasing the uptake of PrEP in young BMSM.


Preexposure prophylaxis HIV Counseling Black men who have sex with men 



We acknowledge that all authors have contributed to this work and have seen and approved the manuscript. The contents of this manuscript have not been published and the manuscript is not being considered for publication elsewhere.


The study was funded by a Grant from the District of Columbia Center for AIDS Research (Grant: P30 AI117970-01).

Compliance with Ethical Standards

Conflict of interest

Author Marc Siegel has received research funding from Gilead Sciences for an unrelated research study. All other authors have no conflicts of interest.

Research Involving Human Participants

The study procedures and all materials were approved by the George Washington University Institutional Review Board and a Certificate of Confidentiality was obtained from the National Institutes of Health for studies with participants under 18 years of age. All study procedures have been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    CDC. Diagnoses of HIV infection in the United States and dependent areas, 2015.
  2. 2.
    District of Columbia Department of Health HIV/AIDS, Hepatitis, STD, and TB Administration. The annual epidemiology & surveillance report. 2017.
  3. 3.
    Jenness S, Goodreau S, Rosenberg E, et al. Impact of the centers for disease control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. J Infect Dis. 2016;214(12):1800–7.CrossRefGoogle Scholar
  4. 4.
    Kasaie P, Pennington J, Shah M, et al. The impact of preexposure prophylaxis among men who have sex with men: an individual-based model. J Acquir Immune Defic Syndr. 2017;75(2):175–83.CrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014 clinical practice guideline.
  6. 6.
    Grant R, Lama J, Anderson P, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefGoogle Scholar
  7. 7.
    Molina J, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.CrossRefGoogle Scholar
  8. 8.
    Wheeler D, Fields S, Nelson L, et al. HPTN 073: PrEP uptake and use by black men who have sex with men in 3 US cities (abstract: 883LB). Presented at: The Conference on Retroviruses and Opportunistic Infections. Boston, MA; 2016.Google Scholar
  9. 9.
    Mera R, McCallister S, Palmer R, et al. Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States (2013–2015). Presented at: 21st International AIDS Conference. Durban, South Africa; 2016.Google Scholar
  10. 10.
    Mera R, Magnuson D., Trevor H, Bush S, Rawlings K, McCallister S. Changes in Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: (2012–2016). Presented at: 9th IAS Conference on HIV Science. Paris, France; 2017.Google Scholar
  11. 11.
    Bush S, Magnuson D, Rawlings K, et al. Racial characteristics of FTC/TDF for pre-exposure prophylaxis (PrEP) users in the US. Presented at: American Society for Microbiology Microbe. Boston, MA; 2016.Google Scholar
  12. 12.
    Patrick R, Forrest D, Cardenas G, et al. Awareness, willingness, and use of pre-exposure prophylaxis among men who have sex with men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014. J Acquir Immune Defic Syndr. 2017;75(Suppl 3):S375–82.CrossRefGoogle Scholar
  13. 13.
    Levy M, Magnus M, Kuo I, et al. An evaluation of the PrEP care continuum among men who have sex with men aged 16-25 in Washington, DC. Presented at: HIV Research for Prevention. Chicago, IL; 2016.Google Scholar
  14. 14.
    Irvin R, Wilton L, Scott H, et al. A study of perceived racial discrimination in Black men who have sex with men (MSM) and its association with healthcare utilization and HIV testing. AIDS Behav. 2014;18(7):1272–8.CrossRefGoogle Scholar
  15. 15.
    Eaton L, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, Cherry C. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health. 2015;105(2):e75–82.CrossRefGoogle Scholar
  16. 16.
    Eaton L, Driffin D, Smith H, et al. Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among black men who have sex with men attending a community event. Sex Health. 2014; 11(3):244–51CrossRefGoogle Scholar
  17. 17.
    Centers for Disease Control and Prevention. Reportable STDs in young people 15–24 years of age, by state.
  18. 18.
    Harris P, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefGoogle Scholar
  19. 19.
    Taylor S, Psaros C, Pantalone D, et al. “Life-Steps” for PrEP adherence: demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cogn Behav Pract. 2017;24(1):38–49.CrossRefGoogle Scholar
  20. 20.
    Smith D, Van Handel M, Wolitski R, et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent hiv acquisition-United States, 2015. J Miss State Med Assoc. 2015;56(12):364–71.Google Scholar
  21. 21.
    Krakower D, Ware N, Mitty J, et al. HIV providers’ perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18(9):1712–21.CrossRefGoogle Scholar
  22. 22.
    Smith D, Van Handel M, Huggins R. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009–2015. PLoS ONE. 2016;11(6):e0156592.CrossRefGoogle Scholar
  23. 23.
    Petroll A, Walsh J, Owczarzak J, et al. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.CrossRefGoogle Scholar
  24. 24.
    Hosek S, Siberry G, Bell M, et al. The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. J Acquir Immune Defic Syndr. 2013;62(4):447–56.CrossRefGoogle Scholar
  25. 25.
    Young L, Schumm P, Alon L, et al. PrEP Chicago: a randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men. Clin Trials. 2018;15(1):44–52.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Infectious Disease, Department of MedicineGeorge Washington University Medical Faculty AssociatesWashingtonUSA
  2. 2.Department of Epidemiology and BiostatisticsMilken Institute School of Public Health at the George Washington UniversityWashingtonUSA

Personalised recommendations